Clinical laboratories around the world are helping to improve patient care while navigating an evolving health care environment. To help laboratories with increasing demands, Abbott (NYSE: ABT) is developing diagnostic solutions for today and tomorrow, which it will showcase during the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, July 27 through July 31, 2014, in Chicago.
Sysmex America, Inc., the United States subsidiary for Sysmex Corporation, Kobe, Japan, announced that the company’s President and Chief Executive Officer, John Kershaw, has been appointed an Executive Officer of Sysmex Corporation. Kershaw’s appointment marks the first time an executive from an overseas subsidiary has been appointed. As an Executive Officer, Kershaw will serve in a consultative capacity to the corporation’s president and governing board while maintaining his leadership position with Sysmex America.
Picture yourself at a work event. What are you wearing? What are you talking about? How loud are you talking? If you indulge at all, how much have you had to drink? Now picture yourself on a weekend trip with a group of friends.
(Reuters) – AstraZeneca took a major step to build up its respiratory medicine business on Wednesday by striking a deal worth up to $2.1 billion for the rights to Spanish group Almirall’s lung drugs.
The British drugmaker, which resisted a $118 billion takeover attempt by Pfizer in May, said it would pay an initial $875 million and up to $1.22 billion more if the drugs meet development and sales targets.
Announcing Ask Us Anything, a Virtual Entrepreneur or Subject Matter Expert Form. This is our “Ask Amy” or “GQ Style Guy” equivalent. It is a forum for current, would be, and want to be entrepreneurs to ask any and all questions relating to the community, being an entrepreneur and starting up a company.
Your questions can be anonymous, so ask all of those little questions you have always wanted to ask. We will go out and find the right expert to answer your question and post the responses every week.
Earlier this month, MoneyTree released its quarterly venture capital report, and the news was overwhelmingly positive. VCs invested almost $13 billion in 1,114 U.S. startups during the second quarter, which is the highest level of VC funding in 13 years.
Hospira has emerged as a bidder for Danone’s medical-nutrition unit, which makes food for the sick, young and elderly, in a deal that could be worth about $5 billion and is the latest in a flurry of tax inversion deals designed to sidestep U.S. taxes,The Wall Street Journal reports.